SK

Sanjeev Kumar Balyan

Director Director DIN 03089529
DIN 03089529 First appointment Aug 2010 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjeev Kumar Balyan

Data last updated:

Sanjeev Kumar Balyan was a Director at Awaday Healthcare Private Limited (2010–2011) and Director at Grensan Pharmaceuticals Private Limited (from 2012). The companies operate in Trading.

DIN 03089529
Primary Designation Director
Industry Trading
First Appointment 20 Aug 2010
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Awaday Healthcare Private Limited U33110DL2010PTC207376
Director20 Aug 20102010₹10 Lakh (FY 2017)Strike Off
Director27 Jan 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Grensan Pharmaceuticals Private Limited
Awaday Healthcare Private Limited
Premium access

Shareholding and investment profile for Sanjeev Kumar Balyan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjeev Kumar Balyan

Sanjeev Kumar Balyan was first appointed on 20 Aug 2010 as Director at Awaday Healthcare Private Limited. The most recent appointment on record is 27 Jan 2012 at Grensan Pharmaceuticals Private Limited.

Sanjeev Kumar Balyan held 2 earlier board appointments: Awaday Healthcare Private Limited (Director, 20 Aug 2010 to 19 Dec 2011); Grensan Pharmaceuticals Private Limited (Director, from 27 Jan 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available